HK1243708A1 - 用於製備2-糠酸衍生物的合成方法 - Google Patents
用於製備2-糠酸衍生物的合成方法Info
- Publication number
- HK1243708A1 HK1243708A1 HK18103282.1A HK18103282A HK1243708A1 HK 1243708 A1 HK1243708 A1 HK 1243708A1 HK 18103282 A HK18103282 A HK 18103282A HK 1243708 A1 HK1243708 A1 HK 1243708A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparing
- acid derivatives
- synthetic process
- furoic acid
- furoic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562112519P | 2015-02-05 | 2015-02-05 | |
| PCT/US2016/016619 WO2016126975A1 (en) | 2015-02-05 | 2016-02-04 | Synthetic process for preparing 2-furoic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1243708A1 true HK1243708A1 (zh) | 2018-07-20 |
Family
ID=55410252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18103282.1A HK1243708A1 (zh) | 2015-02-05 | 2018-03-08 | 用於製備2-糠酸衍生物的合成方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9975867B2 (zh) |
| EP (1) | EP3253743B1 (zh) |
| JP (1) | JP6726670B2 (zh) |
| KR (1) | KR20170115065A (zh) |
| CN (1) | CN107567441A (zh) |
| AU (1) | AU2016215230A1 (zh) |
| CA (1) | CA2975922A1 (zh) |
| DK (1) | DK3253743T3 (zh) |
| ES (1) | ES2742412T3 (zh) |
| HK (1) | HK1243708A1 (zh) |
| PL (1) | PL3253743T4 (zh) |
| PT (1) | PT3253743T (zh) |
| WO (1) | WO2016126975A1 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10544118B2 (en) | 2018-06-25 | 2020-01-28 | Eastman Chemical Company | Oxidation process to produce 5 methyl 5-methylfuran-2-carboxylate (MMFC) |
| US11440895B2 (en) | 2018-06-25 | 2022-09-13 | Eastman Chemical Company | Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) |
| US11236199B2 (en) * | 2018-06-25 | 2022-02-01 | Eastman Chemical Company | Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) |
| CN114364662A (zh) | 2019-09-05 | 2022-04-15 | 伊士曼化工公司 | 用于生产5-(烷氧基羰基)-呋喃-2-甲酸的有效方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4110351A (en) | 1973-04-02 | 1978-08-29 | Richardson-Merrell Inc. | Hypolipidemic agents RO- or RS- substituted furoic acids, esters and salts |
| DE4033563A1 (de) | 1990-10-22 | 1992-04-23 | Henkel Kgaa | Antiseborrhoische zubereitungen |
| US20100204317A1 (en) | 2006-11-03 | 2010-08-12 | Qlt Inc. | Methods of treating dermatological disorders or conditions |
| US8884034B2 (en) * | 2009-07-08 | 2014-11-11 | Dermira (Canada), Inc. | TOFA analogs useful in treating dermatological disorders or conditions |
-
2016
- 2016-02-04 PL PL16706095T patent/PL3253743T4/pl unknown
- 2016-02-04 CN CN201680008917.3A patent/CN107567441A/zh active Pending
- 2016-02-04 AU AU2016215230A patent/AU2016215230A1/en not_active Abandoned
- 2016-02-04 DK DK16706095.3T patent/DK3253743T3/da active
- 2016-02-04 JP JP2017541702A patent/JP6726670B2/ja not_active Expired - Fee Related
- 2016-02-04 EP EP16706095.3A patent/EP3253743B1/en active Active
- 2016-02-04 ES ES16706095T patent/ES2742412T3/es active Active
- 2016-02-04 WO PCT/US2016/016619 patent/WO2016126975A1/en active Application Filing
- 2016-02-04 PT PT16706095T patent/PT3253743T/pt unknown
- 2016-02-04 CA CA2975922A patent/CA2975922A1/en not_active Abandoned
- 2016-02-04 KR KR1020177023579A patent/KR20170115065A/ko unknown
- 2016-02-04 US US15/015,569 patent/US9975867B2/en not_active Expired - Fee Related
-
2018
- 2018-03-08 HK HK18103282.1A patent/HK1243708A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170115065A (ko) | 2017-10-16 |
| WO2016126975A1 (en) | 2016-08-11 |
| JP6726670B2 (ja) | 2020-07-22 |
| EP3253743A1 (en) | 2017-12-13 |
| ES2742412T3 (es) | 2020-02-14 |
| JP2018505891A (ja) | 2018-03-01 |
| AU2016215230A1 (en) | 2017-08-10 |
| PL3253743T3 (pl) | 2020-03-31 |
| CN107567441A (zh) | 2018-01-09 |
| PT3253743T (pt) | 2019-09-04 |
| US9975867B2 (en) | 2018-05-22 |
| DK3253743T3 (da) | 2019-08-19 |
| US20160229825A1 (en) | 2016-08-11 |
| CA2975922A1 (en) | 2016-08-11 |
| PL3253743T4 (pl) | 2020-03-31 |
| EP3253743B1 (en) | 2019-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201708142B (en) | Process for preparing 4-amino-pyridazines | |
| PL3325443T3 (pl) | Sposób otrzymywania pridopidyny | |
| GB201509854D0 (en) | Process for preparing mesotrione | |
| IL274439A (en) | Process for making Tapinaroff | |
| GB2531940B (en) | Process for preparing methotrexate formulation | |
| HUE053818T2 (hu) | Eljárás HMF elõállítására | |
| IL253877A0 (en) | Process for preparing 3-chloro-2-vinylphenylsulfonates | |
| HK1245792A1 (zh) | 製備α-甲酰胺吡咯烷衍生物的方法 | |
| HK1243708A1 (zh) | 用於製備2-糠酸衍生物的合成方法 | |
| HK1255014A1 (zh) | 製備取代5，6-二氫-6-苯基苯並[f]異喹啉-2-胺的方法 | |
| PT3166923T (pt) | Processo para preparar fenilalcanos substituídos | |
| ZA201801650B (en) | Process for producing novel 4-benzoazonine derivatives | |
| HUE054626T2 (hu) | Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására | |
| ZA201908452B (en) | Improved process for preparing imetelstat | |
| GB2561089B (en) | Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one | |
| IL248568B (en) | A process for the preparation of dihydroisoxazole derivatives | |
| IL249283B (en) | Process for the preparation of 3-chloro-2-vinylphenol | |
| IL253630A0 (en) | A process for the preparation of modified phenylisoxazoline derivatives | |
| ZA201807441B (en) | Process for preparing oxathiazin-like compounds | |
| IL253830A0 (en) | A process for the preparation of piperidine-4-carbothioamide hydrochloride | |
| GB201414880D0 (en) | Process for making phosphate derivatives | |
| HUP1500034A1 (en) | Process for the preparation of vortioxetine salts |